Skip to main content
UKPMC Funders Author Manuscripts logoLink to UKPMC Funders Author Manuscripts
. Author manuscript; available in PMC: 2016 Apr 19.
Published in final edited form as: J Empir Res Hum Res Ethics. 2013 Oct;8(4):1–18. doi: 10.1525/jer.2013.8.4.1

Consent and Community Engagement in diverse research contexts: Reviewing and developing research and practice

Participants in the Community Engagement and Consent Workshop, Kilifi, Kenya, March 2011
PMCID: PMC4836561  EMSID: EMS63861  PMID: 24169417

Abstract

consent and community engagement (CE) in health research are two aspects of a single concern—that research is carried out in a respectful manner where social value is maximized. There are important overlaps and interdependencies between consent and CE; for example, CE can provide insights into how best to tailor consent to context and can be an important component of consent processes. Engaging communities can also have intrinsic and instrumental value beyond consent; for example, as a means of showing respect and identifying appropriate ways of working respectfully. In this paper we critically examine how CE and consent processes are characterized, conducted, and evaluated in diverse health research contexts, and propose a preliminary research agenda to support future learning in these critical areas.

Keywords: Consent, community engagement, research, Africa, Asia, research ethics


Consent and community engagement (CE) are two aspects of a single concern—that research is carried out in a way that is respectful to individuals and communities, where social value is maximized. Consent is more clearly defined in the literature than CE, but there are important overlaps and interdependencies between the two concepts, and the way they are applied in health research practice. In both cases, effective and appropriate processes require the balancing of internationally recognized standards of good practice with responsiveness to the local context (Bull, Farsides, & Tekola Ayele, 2012). However, there are relatively few published data on how this might be done, particularly in CE in “traditional,” nonparticipatory, biomedical research contexts. Newman (2006) notes:

Engaging vulnerable community stakeholders in medical research is less of a controlled and predictable science than we might wish. Nevertheless, it seems curious that we invest millions of dollars in product development, clinical training, design and building of facilities … but often leave vital processes of CE largely to trial and error (p. 302).

In order to share literature, ideas, experiences, and needs regarding CE and consent for health research, we organized a four-day international collaborative workshop in Kilifi, Kenya, in early 2011. The workshop brought together groups engaging in research and practice with CE and consent in collaborative global health research from universities and research centers in South Africa, Malawi, Kenya, Botswana, Brazil, Uganda, Burma/Myanmar, Cambodia, Thailand, Peru, Bangladesh, Canada, and the United Kingdom. A breadth of disciplinary backgrounds and perspectives were represented, including bioethics, philosophy, law, anthropology, human geography, psychology, tropical/clinical medicine and clinical trials, science communication, education, gender and development, theology, and health policy. Under the broad topics of CE, consent, or cross-cutting issues, participants either gave conceptual talks based on literature, or presented new empirical research and experiences. Theoretical, methodological, ethical, and research implications of the presentations were discussed. Thus the workshop served as an opportunity for a diverse range of actors to evaluate the current state of knowledge regarding consent and CE, based both on the literature and on experience from a number of key sites. Over the course of the workshop, consensus on key lessons, challenges, and research needs began to emerge.

This paper draws on both the literature and workshop discussions to present an overview of current thinking about, and experiences with, consent and CE in health research. Following introductory material about consent and CE and the interplay between them, the paper is divided into three thematic sections, concerning consent, CE, and cross-cutting issues in turn. We conclude with proposals for research and action that we hope will encourage discussion and input from others.

Consent and CE in Health Research

Consent and CE are frequently dealt with separately in health research literature. Consent has long been considered as a core requirement for the ethical conduct of biomedical research. The concept is relatively clearly defined, with valid consent to research with competent adults entailing: (1) researchers adequately explaining the proposed study; (2) prospective participants understanding what is being proposed; and (3) prospective participants being able to make a free choice about joining the study (Nuffield Council on Bioethics, 2002). Challenges to achieving these components have been observed all over the world (Edwards et al., 1998; Flory & Emanuel, 2004; Mandava et al., 2012), and are potentially exacerbated in low-income settings by greater inequities in resources, power, and information among stakeholders in research (Nuffield Council on Bioethics, 2002; United States National Bioethics Advisory Commission, 2001). There are also differences in cultural practices around communitarian and individual decision making that can impact the conduct of consent processes for specific participants.

Community engagement has long been promoted in health delivery, and is a core value in participatory health research. Recently, and partly in response to challenges arising when seeking consent, CE has begun to be promoted as an important component of the research process in more “traditional,” nonparticipatory research (Tindana et al., 2007). CE is promoted in these situations as a potential approach to strengthen the protection of, respect for, and empowerment of participant communities, and to improve the relevance and quality of research (Doumbo, 2005; Emanuel et al., 2004; Marsh et al., 2008; Marshall & Rotimi, 2001; Tindana et al., 2007). There is no universally accepted definition of CE. Descriptions range from efforts to simply improve information sharing and transparency in communities, through more active consultation, to initiatives aimed at ensuring greater control or partnership by community members (Tindana et al., 2007). Some definitions of CE require more than simple information giving. For example, Tindana et al. (2007) note:

In our view, the concept of engagement in research … is the process of working collaboratively with relevant partners who share common goals and interests. This involves “building authentic partnerships, including mutual respect and active, inclusive participation; power sharing and equity; mutual benefit or finding the ‘win–win’ possibility in the collaborative initiative” (p. 1452).

UNAIDS (2011) recommends defining CE as interactions with those from a particular subgroup or geographical community from which trial participants will be drawn, as opposed to other stakeholders. CE can take place at various and multiple stages of research, from study conception and design, through pre-study information giving, to feedback and communication of results. Research centers may also run program-wide CE activities that are not linked to specific studies. Although CE is increasingly promoted in health research, the concept itself, and the way in which it is best implemented in practice, is understudied and contested.

Interplay between CE and Consent

There are multiple forms of interplay between CE and individual consent. Marsh et al. (2011) recently described the links between communities and individuals. They argued that community understandings, beliefs, and attitudes influence perceptions of personhood, independent decision making, and views on risks and benefits of research. They also noted that individual participation in research can generate risks and benefits for communities as part of the wider implications of research. For example there may be identification and stigmatization of those linked to individual participants through research, either directly or by association (Marshall, 2004; Morin et al., 2003; Tekola et al., 2009a). Also, benefits given to individual participants within communities may cause intracommunity tensions. Such tensions can have an impact on individual participants’ views and comfort within studies (Gikonyo et al., 2008; Marsh et al., 2010; Molyneux et al., 2012).

These points suggest that (1) consent processes may need support from or be influenced by CE activities and (2) CE may be needed to develop appropriate consent processes. Given these overlaps between CE and consent, CE is often promoted as an essential supplement to consent processes (Doumbo, 2005; Molyneux, Peshu, & Marsh, 2005; Tindana et al., 2007). The Good Participatory Practice guidelines for HIV prevention trials illustrate the potential overlap and mutual support between community sensitization, community consultation, and consent activities (UNAIDS, 2011).

Overlap and interplay between CE and consent are critical to this paper, and the practical ethical challenges presented by these two complementary aspects of good research practice are often cross-cutting. CE activities may aim to inform and strengthen consent processes, and consent may be seen as a multilayered process incorporating CE activities during recruitment. However, CE has far greater potential value than simply supporting consent processes; it has the potential to contribute to a broad range of intrinsic and instrumental goals in research. We first present literature and workshop discussions on consent and CE separately, before returning to interrelationships and cross-cutting challenges in the final section.

Seeking Consent to Research: Examining Processes and Responding to Issues

In contrast to CE, there is national and international guidance and regulation to define how consent to research should be sought. In particular, consent processes must contain appropriate information, information must be provided in an understandable way, and participants must be free to accept or decline to take part in research (Nuffield Council on Bioethics, 2002). Despite broad support for these aims, obstacles to the achievement of these requirements exist in practice.

This section outlines challenges that have been identified when seeking to ensure that consent to participate in research is “genuine,” “valid,” “true,” or “authentic.” We discuss issues relating to information provision, supporting understanding, and voluntary decision making in turn, before discussing approaches to strengthen consent processes. We argue that some of the challenges can potentially be addressed through CE.

Providing Information about Research

There is a lack of consistency in guidance and regulation about what information is essential for research participants to know. Guidelines range from giving general instructions, to providing detailed lists of over 25 items of which participants must be informed (Council for International Organizations of Medical Sciences & World Health Organization, 2002; International Conference on Harmonisation, 1996; World Medical Association, 2008). Topics on which there is widespread agreement are: the purpose of the study; the research procedures involved; the duration of participation; potential risks; potential benefits; participants’ rights to decline to take part or to withdraw from research without penalty; treatment and compensation available for research-related harms; and confidentiality. There is also awareness that the above items do not provide an exhaustive list of topics that participants may want or need to be informed about (see Figure 1). Research teams may need to draw upon previous or ongoing research and CE activities to identify additional information of importance to potential participants and communities. For example, significant amounts of basic healthcare information may need to be provided to enable participants to make sense of details of a specific study (Boga et al., 2011; Bull et al., 2012).

FIG. 1. Explaining the rationale of research.

FIG. 1

There is some debate about how much information should be supplied about each topic in the consent process (Berger et al., 2009; Lynoe & Hoeyer, 2005), and about how much variation is necessary or appropriate for different sites in a multicenter study (de Vries et al., 2011; Marshall, 2008). It has been argued that “fully informed consent” is neither a possible nor desirable goal when recruiting participants (Nuffield Council on Bioethics, 2002). Instead, researchers have an obligation to ensure that appropriate information is provided in a comprehensible manner. Recent trends of longer and increasingly legalistic consent forms have raised concerns among researchers (Berger et al., 2009; Nuffield Council on Bioethics, 2005). A particular concern is that overloading participants with information may impair their understanding of aspects of the research of particular importance to them (Molyneux, Peshu, & Marsh, 2004). In addition, it may be difficult to engage with participants about aspects of research that researchers consider important but that participants consider to be of relatively little interest and relevance (Ndebele et al., 2012; Tindana et al., 2012).

Another important aspect of information sharing concerns who is providing the information. Those who might best be able technically to give out the information (for example, clinicians) may not be the people best able to communicate with the potential participant in terms of age, gender, or awareness of the sociocultural background of the person (Fitzgerald et al., 2002).

Understanding

Empirical ethics research in resource-poor settings has identified a number of issues arising in practice relating to participants’ comprehension of study information and factors affecting comprehension (Bhansali et al., 2009; Kass, Maman, & Atkinson, 2005; Pace, Emanuel et al., 2005; Pace, Talisuna et al., 2005); effects of interventions to improve comprehension (Joseph et al., 2006; Ndebele et al., 2012; Penn & Evans, 2010; Sarkar et al., 2010; Vallely et al., 2010); means of evaluating comprehension (Lindegger et al., 2006; Molyneux et al., 2007); and participants’ and communities’ understandings and perceptions of research.

These studies demonstrate that there is often limited understanding among research participants about specific aspects of a study and, in some cases, of the entire purpose of the activity. Thus, for example, “therapeutic misconceptions”—where research activities are incorrectly perceived to be primarily for the benefit of the individual research participants—have been widely documented around the world (Appelbaum, Lidz, & Grisso, 2004; Molyneux, Peshu, & Marsh, 2005). A related concept is “crowding out,” where elements of research are understood but not prioritized by participants who may be more concerned with immediately relevant or understandable healthcare elements of research (Marsh et al., 2011). Where there is crowding out of research information, participants over time may come to describe the research activity as more of a health check (Craig, Reilly, & Bland, 2012). Participants’ inaccurate descriptions of research are not necessarily due to a lack of understanding of the nature and purpose of a study, but to a complex interplay of factors including type of research, broader contextual issues such as poverty and constrained public healthcare services, and participants’ hopes, previous experiences with research and healthcare, and other psychological factors (Glannon, 2006).

Research participants’ understanding can be improved by including explanations of the differences between research and routine care, and of research procedures to be used, as well as their justification and personal implications. In a study conducted in Malawi among women of low literacy, it was demonstrated that trial participants’ understanding was improved by relating research and research procedures to daily life (Ndebele et al., 2012).

There is some ambiguity in the international guidelines about whether researchers’ responsibilities are limited to providing information in an understandable way or whether they should also assess understanding of a study before consent is obtained (International Conference on Harmonisation, 1996; World Medical Association, 2008). Approaches taken in practice have ranged from those that require no formal review of participants’ understanding before consent is obtained, to those requiring prior assessment of understanding via a standardized test. Researchers have noted that assessing understanding in many research contexts may not be straightforward. Means of assessing understanding may be unfamiliar and confusing for participants (Krosin et al., 2006; Molyneux et al., 2007), and the choice of method used to assess understanding may significantly affect the results received (see Figure 2). When assessment of understanding is required, issues arise about whether participants should be excluded from research that offers some benefit but minimal risk if they are unable to answer key questions about the study (Kamuya et al., 2013; Molyneux, Kamuya, & Marsh, 2010; Molyneux et al., 2007).

FIG. 2. Field experiences: Developing alternative methods of assessing understanding.

FIG. 2

Bioethics literature has also drawn a distinction between understanding and acceptance (Beauchamp & Childress, 2001). While participants may adequately understand the information that is transmitted to them, they may not necessarily believe or accept this information, thus invalidating consent. In a study in Nigeria authors found that approximately 25% of participants understood that they were in a clinical trial of an antiretroviral drug, but found it hard to believe that good doctors would provide them with a medicine that was not already known to be effective (Manafa, Lindegger, & Ijsselmuiden, 2007).

Voluntariness, Motivations, and Decision Making

A further challenge identified is that of ensuring that consent to research is voluntary. Voluntariness involves intention and (perceived) freedom from control by external factors (Bull & Lindegger, 2011). Factors that can impact on voluntariness include social and gender norms. Such factors are problematic to consider in consent evaluations: cooperative decision making among spouses may be voluntary, or a wife may feel she has no choice but to hand over decision making to her husband (Kamuya, Marsh, & Molyneux, 2011). Concerns also arise when senior community members purport to consent to research on behalf of a community, rather than considering their role as authorizing recruitment among community members (Tindana, Kass, & Akweongo, 2006). Economic constraints can also lead to participants wishing to join studies to access study-related benefits, in some cases despite significant reservations or with only a limited understanding of some aspects of the research (Leach et al., 1999).

There are a number of examples of research evaluating voluntariness of participation and social and economic factors affecting voluntariness (Abdool Karim et al., 1998; Barsdorf & Wassenaar, 2005; Kass et al., 2005; Marshall et al., 2006; Pace, Emanuel et al., 2005; Pace, Talisuna et al., 2005; Woodsong & Karim, 2005). Further studies examine decision-making processes and the involvement of others in these, and motivations for consenting or declining to take part in research (Kass et al., 2005; Masiye et al., 2008; Mfutso-Bengo et al., 2008; Molyneux et al., 2005; Mtunthama et al., 2008; Nabulsi, Khalil, & Makhoul, 2010; Tindana et al., 2006; Woodsong & Karim, 2005).

Emerging from these studies is the conclusion that subjective experiences of social and economic constraints on voluntariness are neither uniform nor necessarily predictable. Guidance requires that researchers do not deliberately seek to restrict participants’ voluntary decision making via coercion or undue inducement. However, the extent of researchers’ responsibilities to assess subjective experiences of other economic and social constraints on participants’ decision making is not so clear (Bull & Lindegger, 2011). Moreover, determining what decisions have actually been made, and how to respond to non-verbal communication, can be far from straightforward, as illustrated by the concept of “silent refusals” (Kamuya et al., 2013) (Figure 3).

FIG. 3. Field experiences: Silent refusals.

FIG. 3

Questions also arose at the workshop about whether and how researchers should respond to some modes of decision making by individuals and communities. Examples discussed included community leaders requiring certain conditions to be met prior to recruitment, such as employment of particular individuals, and individuals seeking to join studies by approaching researchers and asking to whom they can sell their blood (Figure 4).

FIG. 4. Field experiences: Interactions with gatekeepers.

FIG. 4

Responding to Recognized Challenges

Attendees at the Kilifi workshop discussed how researchers should respond to challenges to ensuring appropriate information is provided, that understanding is facilitated, and free decision making is supported. Suggestions are summarized for the different stages of research in Table 1, and include careful consideration of the design of consent processes and engagement with communities from the outset.

TABLE 1. Strategies to Strengthen Consent Processes Prior to and During Recruitment, and Over the Course of Research.

Prior to Recruitment During Recruitment During Research
  • Engaging with community advisory groups and recruitment staff to determine the appropriate design of consent processes

  • Seeking to understand how local or indigenous knowledge makes sense of research in general, or particular research projects

  • Discussing the research with research ethics committees and seeking approval of designs

  • Negotiating amendments to consent processes developed in different contexts where relevant

  • Building capacity within recruitment staff to explain the research and answer questions appropriately

  • Discussing and publicizing agreed research via meetings, leaflets, flyers, loudspeakers, television, and radio

  • Discussing research with and providing information sheets to potential participants and, where appropriate, others such as family members and communities

  • Ensuring that research makes sense to participants and that the implications of participation are understood

  • Determining whether participants are still willing to take part in research

  • Continuing to engage with the communities and other stakeholders where relevant to identify and respond to emerging concerns

Designing Consent Processes and Supporting the Staff Who Implement Them

There is significant variation in the modes of design of consent processes, from researchers being asked to use information sheets and consent forms developed for overseas populations, to researchers designing a consent process from scratch. The development of templates which incorporate contextually relevant and needed information for specific settings can help (see, for example, Boga et al., 2011). In practice, consent processes are often developed with minimal resources, because limited funding is available before ethical approval is received, or there are limited resources for such development in the research budget. Such constraints may also limit the amount of training that recruiters receive before a study begins. The quality of consent processes will depend on recruiters’ ability to explain and discuss research (Kamuya et al., 2013; Madhavan et al., 2007).

In designing consent processes and in training recruiters, it is useful to distinguish between legal and ethical conceptions of consent. Faden, Beauchamp, and King (1986) argue that legalistic notions of consent create a potentially adversarial relationship between doctor and patient, in which consent is seen as a mechanism to provide the doctor or researcher with legal indemnity. By comparison the ethical conception regards consent as a shared decision-making process, which is the embodiment of a higher level of moral commitment. The latter focuses on empowering people to make good decisions about participation that they do not later regret (Lindegger & Richter, 2000).

Considering Community-wide Activities Prior to and Following Recruitment as Key to Consent Processes

Critical prerequisites to recruitment may include seeking advice and permission from community representatives, such as community leaders and elders, or community advisory groups. These groups may also advise on the design and content of the consent processes, including information-sharing activities with potential communities and participants. Discussions about a study prior to recruitment should ideally involve a two-way learning process. Researchers learn about the relevant communities and the implications of the research for communities and community members. Potential participants learn about the value and procedures associated with the research, and the implications of taking part.

Researchers may need to conduct formative research to strengthen their understanding of issues and local communities before embarking on any recruitment initiatives. They may also need to add additional engagement activities with communities as questions and concerns about research emerge (see Figure 5).

FIG. 5. Field experiences: Blood samples and the Mafessta study in Malawi.

FIG. 5

In addition to engagements relating to specific studies, some research institutions conduct activities aimed at improving general understanding between researchers and community members. For example, a team of community facilitators at the Agincourt Health and Socio-demographic Surveillance System in South Africa have coined the term “building a research-savvy community” to describe their work of continuous coordinated interactions between facilitators and community members over the course of multiple studies. A research-savvy community is seen as a community that is well informed about research, and that is able to engage in an informed way with specific consent processes and the wider research institution. This is ultimately aimed at contributing to high-quality, locally important research that can be sustained over time.

Community Engagement: The Spectrum of Activities and Emerging Issues

There is a long history of community participation and engagement in health delivery, and CE is the core value in participatory health research. However, there is relatively little guidance available on what CE is, and how CE processes should be conducted in biomedical research contexts. Sites that have published their experience have highlighted significant benefits and challenges (Bandewar, Kimani, & Lavery, 2010; Brieland, 1971; Marsh et al., 2008; Marsh et al., 2010; Morin et al., 2003; Morin et al., 2008; Nyika, 2009; Reddy et al., 2010; Shubis et al., 2009; Strauss et al., 2001). Drawing on the workshop and on this literature, in this section we first describe the broad spectrum of activities that might be termed CE, followed by a discussion of the theory and practice of the concepts’ core components. Given the complexity of terms and the range of potentially conflicting goals of CE, we end this section by highlighting the importance of clarifying the range and scope of goals in CE initiatives.

A brief snapshot of the range of activities at different levels

“Community engagement” is an active area of work, encompassing a myriad of activities operating at various levels (Bandewar et al., 2010; Leach & Fairhead, 2007; Marsh et al., 2008; Marsh et al., 2010; Tindana et al., 2007; Tindana et al., 2011). Participatory (action) research is by definition a form of CE with associated ethical dilemmas and approaches (Bastida et al., 2010; Brugge, 2012; Shore et al., 2008), and there is much to learn about CE from participatory research approaches. However, as noted above, in this paper we are focusing on CE in more “traditional,” nonparticipatory biomedical research contexts.

Many research institutions with a long-term presence in the geographical areas where they conduct their research conduct a diverse range of CE activities (Table 2). CE activities may be institution wide (such as those sharing information about research and the research institution with entire communities) or designed for specific studies. Program-wide and study-specific CE sometimes overlap. For example, during community meetings, information could be provided about the research institution and about a particular study. Several research institutions have a group of staff with CE as their main remit. Multiple materials may be used including leaflets, facts sheets, posters, videos, or other forms of “edutainment” (Treffry-Goatley, Mahlinza, & Imrie, 2013).

TABLE 2. An overview of CE Activities and Reported outcomes for Research Centers participating in the Meeting.

CE Activities Reported Outcomes
  • Consultation and opinion seeking
    • With “representatives” including opinion leaders (for example, chiefs and elders, women’s group leaders), or typical members of the community, including through specifically established advisory groups
    • Through social science studies
  • Interaction and information sharing with entire communities, including feedback
    • Public meetings in communities (for example, schools, health facilities, churches and mosques, community meeting areas or “cafes”), often including “edutainment”
    • Inviting community members and representatives into the research center or health facilities
    • Participating in traditional and local government council meetings regularly and on an ad hoc basis
    • Holding participatory workshops
  • Targeted interaction and information sharing with potential participants for specific studies

  • Positive outcomes
    • For studies - better designed and communicated studies, and therefore more informed participants who are better motivated and less likely to withdraw
    • For participants and their communities - better understanding of studies and access to healthcare
    • Relationships - better mutual understanding between researchers, research institutions, and community members; and improved partnerships and relationships between researchers and community members, traditional leadership, and local government departments and authorities, including mutual respect and trust
  • Perverse outcomes
    • Imparting incomplete knowledge - the potential for some information (for example, voluntariness in clinical research) leading to concerns about and refusal of standard clinical care procedures

Beyond the geographical areas in which research institutions are based, involvement of communities also takes place at national and international levels through, for example, community members’ involvement in the development of international guidelines. The 2008 Good Participatory Practice guidelines for HIV trials incorporated contributions from representatives of communities in multiple countries. Community members have also been involved in the design and review of studies, including the design of consent processes for those studies (see, for example, Cheah et al., 2010; Terry et al., 2007; Tindana et al., 2011; Vallely et al., 2010; Vanlerberghe et al., 2009).

Defining community

A key challenge emerging in discussions of CE relates to definitions of the core components: “community,” “engagement,” and “representation.” Broadly, definitions of community can be based on geography, on special interests or goals, or on shared situations or experiences (Ragin et al., 2008). For individuals, community membership may be choice based (for example, membership in a women’s group) or linked to characteristics (such as age or ethnic group). People are always members of multiple communities, with membership shifting over time and space. Membership of communities may be internally or externally defined. In much healthcare research, relevant communities are often initially defined by researchers who are external to communities (Marsh et al., 2011). Definitions of communities are therefore often related to the nature of the research activity (e.g., does it involve a particular geographical area or illness group?) and location of the research institution (e.g., is it based in a rural or urban setting?).

A study or the CE for a study can lead to the disruption or the creation of communities (Bandewar et al., 2010; Gikonyo et al., 2008). For example, Bandewar et al. (2010) describe the creation of a community of sex workers in Nairobi, where no such community existed before. They note that the risks and benefits of research, including the social implications, can serve as the common bond that effectively turns disparate individuals into a community for the purposes of research.

At all levels, but particularly at national and international levels, the distinction between “CE” and “public engagement” is blurred. Depending on how communities are defined, any interactions with research stakeholders, such as Ministries of Health, ethics committees, policy makers, international organizations, the media, and universities, could be considered a form of CE.

Defining engagement

The brief snapshot of CE below (Table 2) points to a whole spectrum of approaches, mechanisms, and practices that might be termed “engagement.” Engagement can include communities coming into research institutions or environments (e.g., visits, exhibitions, student placements), and institution staff going out to be with communities (e.g., participatory training, science cafes, drama, school visits). Activities can be continuous or one-off initiatives, and may be led or coordinated by members of a research team, by a group of community liaison officers or social scientists attached to the research center or by the communities themselves.

Those who are “engaged with” include the range of communities described above, or more often “representatives” of those communities, and potential participants. Increasingly recognized is the importance of ensuring that engagement includes people who potentially have a key voice in communities, including local leaders, health providers and managers (Lang et al., 2011), and the research staff who interact with communities, such as doctors, nurses, and fieldworkers from local communities (Kamuya et al., 2013; Molyneux & Geissler, 2008; Nyika, 2009; Reynolds et al., 2013).

The Kilifi workshop highlighted the importance of informal “out of work” participation by research staff in community events (for example, weddings and funerals) as a form of engagement. Such forms of engagement are typically beyond the formal remit of CE plans, but are potentially important in shaping community members’ views of research and research institutions. Thus, in addition to community liaison staff, fieldworkers and other institution staff often play an important role formally or informally at the “interface” between research institutions and communities (Kamuya et al., 2013; Molyneux, Peshu, & Marsh, 2005; Molyneux & Geissler, 2008; Molyneux et al., 2010; Reynolds et al., 2013).

Frameworks developed to evaluate community participation in healthcare (Arnstein, 1969; Loewenson, 2000) highlight that the creation of opportunities for involvement and consultation do not in themselves lead to community influence and control. In these frameworks the potential for “manipulation” or “token efforts” in initiatives is incorporated; a concern also raised by Slevin et al. in their background paper for AIDS2031 (Slevin, Morenike, & Lori, 2013). Concerns to avoid tokenism contribute to some definitions of CE requiring more than simple information giving, as noted in the introduction.

Representing communities

Cross-cutting the complexity of definitions of community and engagement is the different uses of the word “representation” in literature. Community representatives are often considered as central to learning about community priorities and concerns, either for specific studies or across studies (Morin et al., 2003; Morin et al., 2008; Quinn, 2004; Shubis et al., 2009). However the concept can be highly problematic. In some cases representatives are selected to “speak on behalf” of a particular community, in others individuals are considered as representatives in terms of having similar characteristics and views to others in the community (see Figure 6). When approaching potential community representatives it is important to be clear about the form of representation that individuals and groups are expected to have.

FIG. 6. Identifying individuals to speak on behalf of communities.

FIG. 6

Important challenges for working with community representatives are: how to select representatives; how to balance motivation of representatives with independence from researchers in a way that facilitates critical and meaningful dialogue; how to ensure the most vulnerable groups and those least likely to be selected or vocal in representative groups are heard; and the potential for personal priorities and needs to dominate discussion (Bandewar et al., 2010; Brieland, 1971; Kamuya et al., 2013; Marsh et al., 2008; Marsh et al., 2010; Morin et al., 2003; Morin et al., 2008; Nyika, 2009; Reddy et al., 2010; Shubis et al., 2009; Strauss et al., 2001). To minimize these challenges, and to ensure interaction with multiple and diverse communities, many research institutions and studies engage with a range of representatives, and proactively aim for some form of representation by gender, age, and geography. An emerging concern in approaching representatives in this way is how to deal with differences in views within and across different representative groups. Consideration of these issues highlights the importance of understanding CE not as a prefabricated set of activities that could apply to different settings, but as a dynamic and ever-changing set of negotiated relationships (Lavery et al., 2010).

The importance of clarifying the range and scope of CE goals

CE can simply be about how people behave when they encounter others in the host community, or about how to build on these encounters to achieve goals such as avoiding exploitation, ensuring fair benefits, and correcting historical malpractices. A range of goals were initially raised for CE initiatives in the workshop, including:

  • Conducting successful research—for example, improving recruitment and retention rates

  • Building relationships—trust and partnership

  • Promoting understanding

  • Strengthening capabilities for participants or communities

  • Gaining permission and community consent

  • Satisfying funders’ requirements

  • Satisfying intrinsic values such as respecting participants

  • Identifying and addressing ethical issues

  • Improving healthcare

The above goals or values can be broadly divided into those that are more instrumental, such as engaging communities to improve the quality of research (or simply satisfying funders), and those that are more intrinsic such as engaging communities to show respect or to ensure a sense of inclusion. There may be tensions between instrumental and intrinsic aims where intrinsically valuable community engagement does not achieve researchers’ or research funders’ instrumental goals. An example would be where responsiveness to community feedback leads to a decision not to proceed with a proposed study (Figure 7). Many workshop participants described a mix of both instrumental and intrinsic goals for their initiatives or strategies (see, for example, Figure 6) where the precise combination of aims was not always clearly articulated.

FIG. 7. Situations where studies may not proceed.

FIG. 7

Over the course of the workshop the need for greater clarity on goals for CE emerged as important for three interrelated reasons:

  1. There are potential tensions between differing aims. For example, in providing improved healthcare in response to community-identified needs for essential services, CE activities contribute to community perceptions of the research institution as a health provider, and therefore undermine understanding of research and of consent processes.

  2. All CE has the potential to have a negative impact, at the very least through taking up people’s time, but also through unintended perverse outcomes. Potential adverse outcomes include some individuals feeling obliged to take part in research through peer pressure, and raised expectations that cannot be met (Nyika, 2009; Reynolds et al., 2013). Another example is the danger of half knowing. CE is advocated to reduce therapeutic misconceptions and strengthen understanding of research and therefore informed participation in research (or informed refusal to participate). In practice, however, it can lead to deterioration in understanding through information being inadequately explained, or interpreted in unexpected ways. In Kilifi, for example, information sharing about the difference between research and clinical care, and about the voluntary nature of research, may have led to the rejection of much-needed clinical care on the assumption that the procedure was for research (Marsh et al., 2011).

  3. There is clearly a limit to the ethical issues CE can resolve in research, including those related to historical and background injustices and inequities and poorly resourced health systems. The introduction of new or different benefits for individuals and communities, including improved health services, may be implemented on the basis of community members’ recommendations made during engagement activities. However, it can be helpful to consider benefit sharing (including ancillary care debates) as separate from CE (Molyneux, Peshu, & Marsh, 2005; Molyneux et al., 2012; Tindana et al., 2011).

Beyond the above three reasons for clarity on goals, there is also the more pragmatic need to focus activities—both formal and informal—given the potential range and costs of CE.

Cross-cutting Issues: Relationships and Challenges in Evaluation

The previous two sections have indicated interplays between CE and consent. Throughout the workshop and in the literature, a series of interrelated cross-cutting ethical challenges to strengthening research practice can be highlighted, including complex social inequities, the key role of staff and volunteers working at the interface between researchers and communities, and the centrality of context, as discussed next. The importance and difficulty of including some of these aspects of CE and consent in evaluations are noted.

Complex and shifting relations

Inequalities in social power permeate all CE and consent activities and discussions, including inequalities based on gender, class, age, generation, and color/race/ethnicities. These relationships work in complex and unexpected ways, and in ways that are constantly shifting over time (Cornwall & Jewkes, 1995). At an international level researchers have differential access to research funding and support, and differential abilities to negotiate for approaches to CE and consent that they consider are locally appropriate. At an institutional level, relationships between junior and senior research staff, and between researchers and service providers, can influence the nature and style of partnerships formed, and information shared and acted upon. Studies have shown, for example, that those with different roles in consent processes (e.g., principal investigators and research assistants) may have very different perspectives on consent and when it has been satisfactorily obtained (Lindegger & Van Loon, 2009). Politics can also play a pivotal role in CE and consent, with the nature and depth of engagement of particular communities in some settings depending on who has political authority locally.

Research staff and community representatives who work at the interface between research institutions and local communities constantly engage in and respond to complex power dynamics. For example, the gender of fieldworkers, and the ways in which they interact with different household members, can in some contexts shape the ways in which trust is built or dismantled (Kamuya et al., 2013). Within households and communities, gender roles and relations can also influence resource allocation, power and authority to make decisions about whether or not to consent to study participation, and attendance and inputs in different forms of CE activities (Lang et al., 2011; Molyneux, Wassenaar et al., 2005; Muhwava et al., 2007). Power relations can lead to complex discussions and negotiations within households about research participation (Kamuya et al., 2013); and power relations between patients and providers can lead to voluntariness being compromised.

The centrality of context—sociocultural, political, institutional, and study related (such as age and gender of participants)—is clear. Context influences what key communities might be, and how consent and CE activities might be defined, implemented, or perceived. For example, the history of an institution’s (or senior individuals’) engagement with a community will contribute to levels of trust, which will in turn influence community members’ views about and willingness to participate in engagement activities and studies (Molyneux, Peshu, & Marsh., 2005). Whether a study is facility based or community based, whether or not it involves a health intervention (and the form of the intervention), how sick potential participants are, and what procedures are involved, will all have important implications for power relations between frontline research staff and community members, and levels of stress and interest in research among individual(s) asked to make decisions (Mzimela et al., 2012). Whether communities and potential participants have access to healthcare, irrespective of research participation, will also have an important influence on decision making in some contexts.

Challenges in evaluating interventions

There are challenges to evaluating both CE and consent activities. Conceptual frameworks help identify what is expected to be affected and to develop appropriate methodologies. However, there is rarely a linear relationship between intervention implementation and impact, and it is often impossible to know what would have happened in the absence of what are often complex interventions or sets of interventions.

Although there is more published empirical research from low- and middle-income settings on consent than on CE, there is still relatively little information about the range of issues arising when seeking consent and how best to tailor consent processes to specific contexts. Rapid assessments incorporating a range of qualitative data collection methods such as direct observation, focus group discussions, and semi-structured interviews are a potentially valuable approach (Bull et al., 2012; Tekola et al., 2009b).

Recruitment rates are in themselves inadequate indicators of CE and consent “success,” particularly in the absence of good-quality information on participants’ or nonparticipants’ understanding and voluntariness. Some key goals of interest—for example respect, autonomy, dignity, power, and trust—may be particularly difficult to measure using standard methodological approaches, and require careful conceptualization.

Indications of Best Practice

Different studies will raise different issues and concerns regarding consent, depending on the research design and context in which the studies are conducted. There are also differing implications for overlaps and relationships with CE. The goals for CE, including the links with consent, need careful consideration from the outset, and revision throughout the research process.

Relationship and contextual influences must be considered, and goals and planning of activities clearly articulated, to ensure that both CE and consent activities do not fall into the trap of becoming simplistic “tick-box” activities, or ritualistic initiatives that add relatively little value. Activities also have to be responsive to change in contextual influences, and therefore require monitoring and reflection over time.

Consent

CE and social science can provide insights into populations’ priorities and needs regarding health and research, their understandings of research institutions and activities, the forms of information most needed, and the ways in which potential participants may interpret information about a study and make decisions (Mzimela et al., 2012). In some circumstances a case can be made for ensuring that core funding is available to support ongoing staff training and the staff that recruit participants. The design of resources such as consent templates and standard operating procedures (SOPs), and context-specific consent processes may also be supported. In strengthening consent documentation, it is essential to recognize that consent forms are only a small part of a substantial process including CE. Relevant relationships begin before a specific study is introduced, and change during and on completion of research.

CE

The importance of considering and revising goals before and throughout studies is essential to plan and evaluate CE activities. CE activities should not be seen as a prefabricated set of activities that could apply to different settings, or that are static and set at the outset of any particular study. CE activities should be seen as a dynamic and ever-changing set of negotiated relationships (Lavery, 2010).

Beyond consent and CE, access to medical care and other benefits for individuals and communities during and after studies needs careful consideration in research. These factors are key ethical issues in themselves, are often raised and discussed in community engagement activities, are important to understand as part of information provided about research, and feature strongly in community members’ decision-making processes.

Toward a Research Agenda

Consent and community engagement (CE) are two aspects of a single aim, to support research that is respectful to individuals and communities where social value is maximized. At the Kilifi workshop it became clear during discussions of challenges arising in both CE and consent that achieving this aim in practice is not straightforward, and that many questions arise without simple answers. A need was identified for more social science research into how best to respond to the range of issues identified. Topics ranged from formative research to inform potential future initiatives, to research evaluating how well current initiatives are working. Methodological creativity and innovation is much needed, including both quantitative and qualitative methods, and participatory, deliberative, reflexive, and philosophical approaches. For “empirical ethics” studies—where empirical data are combined with ethical analysis to allow normative claims—there is also scope for new approaches where normative argument and justification are incorporated directly into the process of collecting and analyzing data (Dunn et al., 2012). Community liaison officers and community representatives were underrepresented at the workshop, and so consultation with such key stakeholders will be critical when setting local research agendas.

A range of possible issues to follow up through empirical research have been highlighted in this paper:

Clarifying the goals and value of CE, and how these might differ in different contexts

Research could help describe the range of CE goals/values that have been identified, and inform debates on if and when CE should happen, and in what form. Recommendations are expected to differ for different types of research (e.g., emergency research versus community-based trials involving healthy children) and in different contexts (e.g., politically unstable or mobile populations versus relatively stable populations).

Comparing CE activities and impacts across different types of research and in different contexts

We need detailed descriptions of CE activities, and ways to evaluate their effectiveness. This will in turn require clarifying and comparing the goals and underlying values of activities, and the intended or expected outcomes. We need conceptual frameworks that consider depth of responsiveness to local populations/communities, and documentation of perverse outcomes.

Incorporating relational aspects of consent more centrally into consent plans and evaluations

Trust and power relations play a central but complex role in consent processes. These relational aspects of consent need careful attention, including asking: What are these relational influences? How do they work? What are the implications for consent processes? Do these relations influence who should be involved in consent processes and the support that they need? If so, why and how?

Examining the design and conduct of consent processes

Across many different settings, a range of innovative approaches are aimed at strengthening consent processes, facilitating understanding of studies, and supporting free decision making. These initiatives need to be documented and examined, and the findings shared and reflected upon.

Considering the deliberative spaces in which research institutions and studies operate

Researchers often work with community representatives. Clearer articulation of the similarities and differences between different representative groups is needed, in relation to goals of establishing or working with groups, forms of representation, and intended and actual use of deliberations with representatives in research practice. Specific questions include: Who is representing whom and in what way? How do we ensure that there are “authentic voices” in these discussions? What do we do with differences of opinion? What types of relationships are ultimately established between research institutions and communities? Reflection on experience with current practice would be a useful starting point, followed by carefully designed prospective studies.

Engaging with communities across multicenter studies

As multicenter studies continue to expand, there is an interest in documenting and researching the more specific issues and concerns that emerge from these studies from the perspectives of different actors involved. Innovative participatory approaches could include, for example, bringing together community liaison officers and community members/representatives from different sites to discuss on-the-ground realities, with inputs from ethicists and academics.

Educational Implications

We have focused on CE and consent at the level of interactions between researchers (and institutions) and study communities in international research contexts. The complex and contested nature of consent and especially CE is clear. Educational materials and activities need to clearly define the meanings of communities, engagement, and representation in relation to the goals of CE. Also to be highlighted are challenges to achieving “genuine,” “true,” or “authentic” consent, and therefore the need for innovative approaches to maximizing understanding and voluntariness in different contexts through carefully developing consent processes tailored to local contexts. It is essential to emphasize that neither CE nor consent can be a prefabricated set of activities that is static over time and place; both are dynamic and negotiated relationships. Researchers, ethics committee members, and community members have the potential to benefit from social science studies that incorporate methodological innovation.

Acknowledgments

We are grateful to the Wellcome Trust for funding the meeting at which these issues were discussed (094062). In addition, we acknowledge the Enhancement Award (BXRPOV0) and the Global Health Bioethics Network and the Wellcome Trust (Strategic Award No. 096527) for supporting the contributions of Michael Parker, Susan Bull, and Dina Rippon to the meeting and this paper.

We would like to thank the Kenya Medical Research Institute–Wellcome Trust (KEMRI–WT) Research Programme for hosting the international meeting on community engagement and consent in Kilifi, Kenya, in March 2011. We would specifically like to thank Mary Mariga for her administrative support for that meeting, and especially Dina Rippon for her substantial inputs and support in the runup to, and since, the Kilifi meeting and in coordinating the writing of this paper. We would additionally like to thank Lairumbi Mbaabu for his contributions during the meeting.

Biographies

Authors’ Biographical Sketches

Given the length of the author list, we have only included biographical sketches for the two main authors: Dr. Sassy Molyneux and Dr. Susan Bull. Dr. Molyneux prepared the first draft of the paper and Drs. Bull and Molyneux amended it extensively. The remainder of the authors contributed to the ideas expressed in the paper, and read and commented on the draft manuscript.

Sassy Molyneux is a social scientist employed by the University of Oxford, UK, and based at the Kenya Medical Research Institute–Wellcome Trust Research Programme in Kilifi, Kenya. Her current main research interests include research ethics, including informed consent and community engagement, and health system finance and governance. One theme cross-cutting these research areas is an interest in producing new thinking, evidence, and recommendations around strengthening community involvement in biomedical research and health delivery in sub-Saharan Africa.

Susan Bull is a senior researcher in ethics at the Ethox Centre, University of Oxford. Her research interests are in international research ethics, including the design and conduct of consent processes, ethical issues arising in genomic research in low- and middle-income settings, and data sharing and release. A recurring theme is the appropriate interpretation of international guidance and principles of research ethics in specific research contexts.

Authors

Organizing Committee for the Community Engagement and Consent Workshop, Kilifi, Kenya, March 2011

Susan Bull, Senior Researcher, The Ethox Centre, University of Oxford. susan.bull@ethox.ox.ac.uk

Phaik Yeong Cheah, Clinical Trials Support Group, Mahidol-Oxford Tropical Medicine Research Unit, Thailand, Bangkok. Phaikyeong@tropmedres.ac

Khin Maung Lwin, Shoklo Malaria Research Unit (SMRU), part of the Mahidol-Oxford Research Unit in Maesod, Thai-Myanmar Border. drkhin_mg_lwin@shoklo-unit.com

Vicki Marsh, Health Systems Research Group, KEMRI–Wellcome Research Programme, Kilifi, and Lecturer in the Nuffield Department of Medicine, Oxford University. vmarsh@kemri-wellcome.org

Sassy Molyneux, Wellcome Research Fellow, KEMRI–Wellcome Research Programme, Kilifi. smolyneux@kemri-wellcome.org

Michael Parker, Professor of Bioethics, Director of The Ethox Centre, Department of Public Health, University of Oxford. michael.parker@ethox.ox.ac.uk

Sally Theobald, Senior Lecturer in Social Science and International Health at the Liverpool School of Tropical Medicine (LSTM), UK. sjt@liverpool.ac.uk

Participants in the Community Engagement and Consent Workshop, Kilifi, Kenya, March 2011

Sunita Bandewar, Senior Research Fellow, International Collaborative Initiative in Community Engagement in Global Health, Ethical, Social, and Cultural (ESC) Program for the Bill & Melinda Gates Foundation’s Grand Challenges in Global Health initiative, University of Toronto, Toronto, Canada [at the time of the workshop]. sunita.bandewar@utoronto.ca

Gabriela Calazans, Coordinator of Community Educa tion at the São Paulo HIV Vaccine Trials Unit, at the Reference and Training Center in STD/AIDS (CRT-DST/AIDS) from the São Paulo State Health Department; Professor of Social Sciences applied to Medicine at the School of Medical Sciences of the Santa Casa de São Paulo and Researcher at the Department of Preventive Medicine of the School of Medicine and at the Nucleus for AIDS Prevention, NEPAIDS, of the Universidade de São Paulo, Brazil. gcalazans@crt.saude.sp.gov.br

Tamara Chipasula, Science Communication Officer at Malawi-Liverpool–Wellcome Trust (MW)/College of Medicine (COM). tchipasula@mlw.medcol.mw

Kheng Chheng, Pediatrician, Angkor Hospital for Children (AHC), Siemreap, Cambodia.kh_chheng@yahoo.com

Alun Davies, Researcher and Principal Investigator, Schools Engagement Programme, KEMRI–Wellcome Research Programme, Kilifi, Kenya. adavies@kemri-wellcome.org

Michael Dunn, Lecturer in Health and Social Care Ethics, The Ethox Centre, Department of Public Health, University of Oxford. michael.dunn@ethox.ox.ac.uk

M. A. Faiz, Professor of Medicine (Retired), Dev Care Foundation, Dhaka, Bangladesh. drmafaiz@gmail.com

John Imrie, Social Science Lead, Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa; Principal Research Associate, Centre for Sexual Health and HIV Research, Faculty of Population Health, University College London, London UK. jimrie@africacentre.ac.za

Dorcas Kamuya, Researcher in Ethics and Community Engagement, The Ethox Centre, Department of Public Health, University of Oxford, and Health Systems Research department, KEMRI–Wellcome Trust Research Programme, Kilifi, Kenya. Dkamuya@kemri-wellcome.org

Angeliki Kerasidou, Ethics Co-ordinator, Malaria Genomic Epidemiology Network (MalariaGEN), The Ethox Centre, Department of Public Health, University of Oxford. angeliki@well.ox.ac.uk

James V. Lavery, research scientist in the Centre for Research on Inner City Health (CRICH) and Centre for Global Health Research (CGHR), Keenan Research Centre of the Li Ka Shing Knowledge Institute, St. Michael’s Hospital, and Associate Professor in the Dalla Lana School of Public Health and Joint Centre for Bioethics at the University of Toronto. LaveryJ@smh.ca

Graham Lindegger, Professor of Clinical Psychology, Director of the training program in professional psychology, PI—HIV/AIDS Vaccine Ethics Group, University of KwaZulu-Natal, South Africa. Lindegger@ukzn.ac.za

Eleanor MacPherson, Doctoral student, Liverpool School of Tropical Medicine and Malawi-Liverpool–Wellcome trust clinical program. eleanormacp@googlemail.com

Charles T. Muga, Center for Microbiology Research, Kenya Medical Research Institute (KEMRI). cmuga@rctp.or.ke

Stephen Nakibinge, Regional Administrative Manager (Southern and Western Uganda) AIDS Healthcare Foundation–Uganda Cares. Stephen.Nakibinge@aidshealth.org

Paul Ndebele, Director, Medical Research Council of Zimbabwe. Ndebele@gmail.com

John Sadalaki, Lead Social Science Researcher for MAFESSTA Study, Malawi Liverpool Wellcome Trust/College of Medicine. johnrsadalaki@gmail.com

Janet Seeley, MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda, and School of International Development, University of East Anglia, Norwich. J.Seeley@uea.ac.uk

Mark Sheehan, Oxford Biomedical Research Centre Ethics Fellow, The Ethox Centre, Department of Public Health, and a James Martin Research Fellow in the Institute for Science and Ethics, University of Oxford. mark.sheehan@philosophy.ox.ac.uk

Rhian Twine, Coordinator of the LINC office of the MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), of the School of Public Health, University of the Witwatersrand, South Africa. rhian@agincourt.co.za

Jantina de Vries, Senior Researcher in Bioethics, Department of Medicine, University of Cape Town, South Africa. jantina.devries@uct.ac.za

References

  1. Abdool Karim Q, Abdool Karim SS, Coovadia HM, Susser M. Informed consent for HIV testing in a South African hospital: Is it truly informed and truly voluntary? American Journal of Public Health. 1998;88(4):637–640. doi: 10.2105/ajph.88.4.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Appelbaum PS, Lidz CW, Grisso T. Therapeutic misconception in clinical research: Frequency and risk factors. IRB: Ethics & Human Research. 2004;26(2):1–8. [PubMed] [Google Scholar]
  3. Arnstein S. A ladder of citizen participation. Journal of the American Institute of Planners. 1969;35:216–224. [Google Scholar]
  4. Bandewar SV, Kimani J, Lavery JV. The origins of a research community in the Majengo Observational Cohort Study, Nairobi, Kenya. BMC Public Health. 2010;10:630. doi: 10.1186/1471-2458-10-630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Barsdorf NW, Wassenaar DR. Racial differences in public perceptions of voluntariness of medical research participants in South Africa. Social Science and Medicine. 2005;60(5):1087–1098. doi: 10.1016/j.socscimed.2004.06.039. [DOI] [PubMed] [Google Scholar]
  6. Bastida EM, Tseng TS, McKeever C, Jack L., Jr. Ethics and community-based participatory research: Perspec tives from the field. Health Promotion Practice. 2010;11(1):16–20. doi: 10.1177/1524839909352841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Beauchamp TL, Childress JF. Principles of biomedical ethics. 5th ed. Oxford University Press; Oxford: 2001. [Google Scholar]
  8. Berger O, Gronberg BH, Sand K, Kaasa S, Loge JH. The length of consent documents in oncological trials is doubled in twenty years. Annals of Oncology. 2009;20(2):379–385. doi: 10.1093/annonc/mdn623. [DOI] [PubMed] [Google Scholar]
  9. Bhansali S, Shafiq N, Malhotra S, Pandhi P, Singh I, Venkateshan SP, Talwar KK. Evaluation of the ability of clinical research participants to comprehend informed consent form. Contemporary Clinical Trials. 2009;30(5):427–430. doi: 10.1016/j.cct.2009.03.005. [DOI] [PubMed] [Google Scholar]
  10. Boga M, Davies A, Kamuya D, Kinyanjui SM, Kivaya E, Kombe F, et al. Strengthening the informed consent process in international health research through community engagement: The KEMRI–Wellcome Trust Research Programme Experience. PLoS Medicine. 2011;8(9):e1001089. doi: 10.1371/journal.pmed.1001089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Brieland D. Community advisory boards and maximum feasible participation. American Journal of Public Health. 1971;61(2):292–296. doi: 10.2105/ajph.61.2.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Brugge D. Institutional review boards need to increase their understanding of community-based participatory research: Commentary on a case study in the ethics of mental health research. Journal of Nervous and Mental Disease. 2012;200(3):242. doi: 10.1097/NMD.0b013e318247cb05. [DOI] [PubMed] [Google Scholar]
  13. Bull S, Farsides B, Tekola Ayele F. Tailoring information provision and consent processes to research contexts: The value of rapid assessments. Journal of Empirical Research on Human Research Ethics. 2012;7(1):35–50. doi: 10.1525/jer.2012.7.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Bull S, Lindegger GC. Ensuring consent to research is voluntary: How far do we need to go? American Journal of Bioethics. 2011;11(8):27–29. doi: 10.1080/15265161.2011.585272. [DOI] [PubMed] [Google Scholar]
  15. Cheah PY, Lwin KM, Phaiphun L, Maelankiri L, Parker M, Day NP, et al. Community engagement on the Thai-Burmese border: Rationale, experience and lessons learnt. International Health. 2010;2(2):123–129. doi: 10.1016/j.inhe.2010.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Cornwall A, Jewkes R. What is participatory research? Social Science and Medicine. 1995;41(12):1667–1676. doi: 10.1016/0277-9536(95)00127-s. [DOI] [PubMed] [Google Scholar]
  17. Council for International Organizations of Medical Sciences and World Health Organization . International ethical guidelines for biomedical research involving human subjects. 3rd ed. CIOMS; Geneva: 2002. [PubMed] [Google Scholar]
  18. Craig E, Reilly J, Bland R. Body fatness or anthropometry for assessment of unhealthy weight status? Comparison between methods in South African children and adolescents. Public Health Nutrition. 2012 Oct 4;:1–9. doi: 10.1017/S1368980012004338. [Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. de Vries J, Bull SJ, Doumbo O, Ibrahim M, Mercereau–Puijalon O, Kwiatkowski D, Parker M. Ethical issues in human genomics research in developing countries. BMC Medical Ethics. 2011;12:5. doi: 10.1186/1472-6939-12-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Doumbo OK. Global voices of science. It takes a village: Medical research and ethics in Mali. Science. 2005;307(5710):679–681. doi: 10.1126/science.1109773. [DOI] [PubMed] [Google Scholar]
  21. Dunn M, Sheehan M, Hope T, Parker M. Toward methodological innovation in empirical ethics research. Cambridge Quarterly of Healthcare Ethics. 2012;21(4):466–480. doi: 10.1017/S0963180112000242. [DOI] [PubMed] [Google Scholar]
  22. Edwards SJ, Lilford RJ, Thornton J, Hewison J. Informed consent for clinical trials: In search of the “best” method. Social Science and Medicine. 1998;47(11):1825–1840. doi: 10.1016/s0277-9536(98)00235-4. [DOI] [PubMed] [Google Scholar]
  23. Emanuel EJ, Wendler D, Killen J, Grady C. What makes clinical research in developing countries ethical? The benchmarks of ethical research. Journal of Infectious Disease. 2004;189(5):930–937. doi: 10.1086/381709. [DOI] [PubMed] [Google Scholar]
  24. Faden RR, Beauchamp TL, King NMP. A history and theory of informed consent. Oxford University Press; New York: 1986. [PubMed] [Google Scholar]
  25. Fitzgerald DW, Marotte C, Verdier RI, Johnson WD, Jr., Pape JW. Comprehension during informed consent in a less-developed country. Lancet. 2002;360(9342):1301–1302. doi: 10.1016/S0140-6736(02)11338-9. [DOI] [PubMed] [Google Scholar]
  26. Flory J, Emanuel E. Interventions to improve research participants’ understanding in informed consent for research: A systematic review. Journal of the American Medical Association. 2004;292(13):1593–1601. doi: 10.1001/jama.292.13.1593. [DOI] [PubMed] [Google Scholar]
  27. Gikonyo C, Bejon P, Marsh V, Molyneux S. Taking social relationships seriously: Lessons learned from the informed consent practices of a vaccine trial on the Kenyan Coast. Social Science and Medicine. 2008;67(5):708–720. doi: 10.1016/j.socscimed.2008.02.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Glannon W. Phase I oncology trials: Why the therapeutic misconception will not go away. Journal of Medical Ethics. 2006;32(5):252–255. doi: 10.1136/jme.2005.015685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. International Conference on Harmonisation . ICH harmonised tripartite guideline for good clinical practice (E6) In: ICoHS Committee, editor. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH; Geneva: 1996. [Google Scholar]
  30. Joseph P, Schackman BR, Horwitz R, Nerette S, Verdier RI, Dorsainvil D, Fitzgerald DW. The use of an educational video during informed consent in an HIV clinical trial in Haiti. Journal of Acquired Immune Deficiency Syndromes. 2006;42(5):588–591. doi: 10.1097/01.qai.0000229998.59869.05. [DOI] [PubMed] [Google Scholar]
  31. Kamuya D, Marsh VM, Kombe F, Geissler PW, Molyneux CS. Engaging communities to strengthen research ethics in low-income settings: Experiences and lessons from setting up a network of community representatives in a busy research site. Developing World Bioethics. 2013 doi: 10.1111/dewb.12014. in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kamuya D, Theobald SJT, Munywoki P, Koech D, Geissler PW, Molyneux CS. Evolving friendships and shifting ethical dilemmas: Fieldworkers? Experiences in a short-term community-based intensive household study. Developing World Bioethics. 2013 doi: 10.1111/dewb.12009. in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Kamuya DM, Marsh V, Molyneux S. What we learned about voluntariness and consent: Incorporating “background situations” and understanding into analyses. American Journal of Bioethics. 2011;11(8):31–33. doi: 10.1080/15265161.2011.583328. [DOI] [PubMed] [Google Scholar]
  34. Kass NE, Maman S, Atkinson J. Motivations, understanding, and voluntariness in international randomized trials. IRB: Ethics & Human Research. 2005;27(6):1–8. [PMC free article] [PubMed] [Google Scholar]
  35. Khin ML, Peto TJ, White NJ, Day NPJ, Nosten F, Parker M, Cheah PY. The practicality and sustainability of a community advisory board at a large medical research unit on the Thai-Myanmar border. Health. 2013;5(2):229–236. doi: 10.4236/health.2013.52031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Krosin MT, Klitzman R, Levin B, Cheng J, Ranney ML. Problems in comprehension of informed consent in rural and peri-urban Mali, West Africa. Clinical Trials. 2006;3(3):306–313. doi: 10.1191/1740774506cn150oa. [DOI] [PubMed] [Google Scholar]
  37. Lang TA, Gould J, von Seidlein L, Lusingu JP, Mshamu S, Ismael S, et al. Approaching the community about screening children for a multicentre malaria vaccine trial. International Health. 2012;4(1):47–54. doi: 10.1016/j.inhe.2011.10.003. [DOI] [PubMed] [Google Scholar]
  38. Lavery JV, Tinadana PO, Scott TW, Harrington LC, Ramsey JM, ytuarte-Nunez C,, James AA. Towards a framework for community engagement in global health research. Trends in Parasitology. 2010;26(6):279–283. doi: 10.1016/j.pt.2010.02.009. [DOI] [PubMed] [Google Scholar]
  39. Leach A, Hilton S, Greenwood BM, Manneh E, Dibba B, Wilkins A, Mulholland EK. An evaluation of the informed consent procedure used during a trial of a Haemophilus influenzae type B conjugate vaccine undertaken in The Gambia, West Africa. Social Science and Medicine. 1999;48(2):139–148. doi: 10.1016/s0277-9536(98)00317-7. [DOI] [PubMed] [Google Scholar]
  40. Leach M, Fairhead J, Leach, Fairhead . Vaccine anxieties: Global science, child health and society. Earthscan; London: 2007. Anxieties over science: Engaging vaccine trials in The Gambia; pp. 156–157. [Google Scholar]
  41. Lindegger G, Milford C, Slack C, Quayle M, Xaba X, Vardas E. Beyond the checklist: Assessing understanding for HIV vaccine trial participation in South Africa. Journal of Acquired Immune Deficiency Syndromes. 2006;43(5):560–566. doi: 10.1097/01.qai.0000247225.37752.f5. [DOI] [PubMed] [Google Scholar]
  42. Lindegger G, Richter LM. HIV vaccine trials: Critical issues in informed consent. South African Journal of Science. 2000;96:313–317. [PubMed] [Google Scholar]
  43. Lindegger G, Van Loon K. Informed consent in clinical trials: Perceptions and experiences of a sample of South African researchers. Health SA Gesondheid. 2009;14(1):1–7. [Google Scholar]
  44. Loewenson R. Public participation in health systems in Zimbabwe. IDS Bulletin. 2000;31(1):15–20. [Google Scholar]
  45. Lynoe N, Hoeyer K. Quantitative aspects of informed consent: Considering the dose response curve when estimating quantity of information. Journal of Medical Ethics. 2005;31:736–738. doi: 10.1136/jme.2005.012013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Madhavan S, Collinson M, Townsend NW, Kahn K, Tollman SM. The implications of long-term community involvement for the production and circulation of population knowledge. Demographic Research. 2007;17:369–388. doi: 10.4054/DemRes.2007.17.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Manafa O, Lindegger G, Ijsselmuiden C. Informed consent in an antiretroviral trial in Nigeria. Indian Journal of Medical Ethics. 2007;4(1):26–30. doi: 10.20529/IJME.2007.009. [DOI] [PubMed] [Google Scholar]
  48. Mandava A, Pace C, Campbell B, Emanuel E, Grady C. The quality of informed consent: Mapping the landscape—A review of empirical data from developing and developed countries. Journal of Medical Ethics. 2012;38(6):356–365. doi: 10.1136/medethics-2011-100178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Marsh V, Kamuya D, Rowa Y, Gikonyo C, Molyneux S. Beginning community engagement at a busy biomedical research programme: Experiences from the KEMRI CGMRC–Wellcome Trust Research Programme, Kilifi, Kenya. Social Science and Medicine. 2008;67(5):721–733. doi: 10.1016/j.socscimed.2008.02.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Marsh VM, Kamuya DM, Mlamba AM, Williams TN, Molyneux SS. Experiences with community engagement and informed consent in a genetic cohort study of severe childhood diseases in Kenya. BMC Medical Ethics. 2010;11:13. doi: 10.1186/1472-6939-11-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Marsh VM, Kamuya DM, Parker MJ, Molyneux CS. Working with concepts: The role of community in international collaborative biomedical research. Public Health Ethics. 2011;4(1):26–39. doi: 10.1093/phe/phr007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Marshall PA. The individual and the community in international genetic research. Journal of Clinical Ethics. 2004;15(1):76–86. [PubMed] [Google Scholar]
  53. Marshall PA. “Cultural competence” and informed consent in international health research. Cambridge Quarterly of Healthcare Ethics. 2008;17(2):206–215. doi: 10.1017/S0963180108080237. [DOI] [PubMed] [Google Scholar]
  54. Marshall PA, Adebamowo CA, Adeyemo AA, Ogundiran TO, Vekich M, Strenski T, Rotimi CN. Voluntary participation and informed consent to international genetic research. American Journal of Public Health. 2006;96(11):1989–1995. doi: 10.2105/AJPH.2005.076232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Marshall PA, Rotimi C. Ethical challenges in community-based research. American Journal of the Medical Sciences. 2001;322(5):241–245. [PubMed] [Google Scholar]
  56. Masiye F, Kass N, Hyder A, Ndebele P, Mfutso-Bengo J. Why mothers choose to enrol their children in malaria clinical studies and the involvement of relatives in decision making: Evidence from Malawi. Malawi Medical Journal. 2008;20(2):50–56. doi: 10.4314/mmj.v20i2.10957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Mfutso-Bengo J, Masiye F, Molyneux M, Ndebele P, Chilungo A. Why do people refuse to take part in biomedical research studies? Evidence from a resource-poor area. Malawi Medical Journal. 2008;20(2):57–63. doi: 10.4314/mmj.v20i2.10958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Molyneux CS, Peshu N, Marsh K. Understanding of informed consent in a low-income setting: Three case studies from the Kenyan coast. Social Science and Medicine. 2004;59(12):2547–2559. doi: 10.1016/j.socscimed.2004.03.037. [DOI] [PubMed] [Google Scholar]
  59. Molyneux CS, Peshu N, Marsh K. Trust and informed consent: Insights from community members on the Kenyan coast. Social Science and Medicine. 2005;61(7):1463–1473. doi: 10.1016/j.socscimed.2004.11.073. [DOI] [PubMed] [Google Scholar]
  60. Molyneux CS, Wassenaar DR, Peshu N, Marsh K. “Even if they ask you to stand by a tree all day, you will have to do it (laughter)…!”: Community voices on the notion and practice of informed consent for biomedical research in developing countries. Social Science and Medicine. 2005;61(2):443–454. doi: 10.1016/j.socscimed.2004.12.003. [DOI] [PubMed] [Google Scholar]
  61. Molyneux S, Geissler PW. Ethics and the ethnography of medical research in Africa. Social Science and Medicine. 2008;67(5):685–695. doi: 10.1016/j.socscimed.2008.02.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Molyneux S, Gikonyo C, Marsh V, Bejon P. Incorporating a quiz into informed consent processes: Qualitative study of participants’ reactions. Malaria Journal. 2007;6:145. doi: 10.1186/1475-2875-6-145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Molyneux S, Kamuya DM, Marsh V. Community members employed on research projects face crucial, often under-recognized, ethical dilemmas. American Journal of Bioethics. 2010;10(3):24–26. doi: 10.1080/15265161003708623. [DOI] [PubMed] [Google Scholar]
  64. Molyneux S, Mulupi S, Mbaabu L, Marsh V. Benefits and payments for research participants: Experiences and views from a research centre on the Kenyan coast. BMC Medical Ethics. 2012;13:13. doi: 10.1186/1472-6939-13-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Morin SF, Maiorana A, Koester KA, Sheon NM, Richards TA. Community consultation in HIV prevention research: A study of community advisory boards at 6 research sites. Journal of Acquired Immune Deficiency Syndromes. 2003;33(4):513–520. doi: 10.1097/00126334-200308010-00013. [DOI] [PubMed] [Google Scholar]
  66. Morin SF, Morfit S, Maiorana A, Aramrattana A, Goicochea P, Mutsambi JM, Richards TA. Building community partnerships: Case studies of community advisory boards at research sites in Peru, Zimbabwe, and Thailand. Clinical Trials. 2008;5(2):147–156. doi: 10.1177/1740774508090211. [DOI] [PubMed] [Google Scholar]
  67. Mtunthama N, Malamba R, French N, Molyneux ME, Zijlstra EE, Gordon SB. Malawians permit research bronchoscopy due to perceived need for healthcare. Journal of Medical Ethics. 2008;34(4):303–307. doi: 10.1136/jme.2007.020461. [DOI] [PubMed] [Google Scholar]
  68. Muhwava W, Nyirenda M, Mutevedzi T, Herbst JA, Hosegood V. Operational and methodological procedures of the Africa Centre Demographic Information System. Africa Centre for Health and Population Studies; South Africa: 2007. Monograph Series No. 1. [Google Scholar]
  69. Mzimela M, Gafos M, Ndlovu H, Pool R, Elford J, team, mdp. Women’s reasons for enrolling in a microbicide clinical trial in a predominantly rural area of KwaZulu-Natal, South Africa; (Poster) 2012 International Microbicides Conference; Sydney, Australia. 15-18 April 2012. [Google Scholar]
  70. Nabulsi M, Khalil Y, Makhoul J. Parental attitudes towards and perceptions of their children’s participation in clinical research: A developing-country perspective. Journal of Medical Ethics. 2010;37(7):420–423. doi: 10.1136/jme.2010.035899. [DOI] [PubMed] [Google Scholar]
  71. Ndebele PM, Wassenaar D, Munalula E, Masiye F. Improving understanding of clinical trial procedures among low literacy populations: An intervention within a microbicide trial in Malawi. BMC Medical Ethics. 2012;13(1):13–29. doi: 10.1186/1472-6939-13-29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Newman PA. Towards a science of community engagement. Lancet. 2006;367(9507):302. doi: 10.1016/S0140-6736(06)68067-7. [DOI] [PubMed] [Google Scholar]
  73. Nuffield Council on Bioethics . The ethics of research related to healthcare in developing countries. Nuffield Council on Bioethics; London: 2002. [Google Scholar]
  74. Nuffield Council on Bioethics . The ethics of research related to healthcare in developing countries: A follow-up Discussion Paper based on the workshop held in Cape Town, South Africa 12–14th February 2004. Nuffield Council on Bioethics; London: 2005. [Google Scholar]
  75. Nyika A. Ethical and practical challenges surrounding genetic and genomic research in developing countries. Acta Tropica. 2009;112(Suppl 1):S21–31. doi: 10.1016/j.actatropica.2009.07.034. [DOI] [PubMed] [Google Scholar]
  76. Pace C, Emanuel EJ, Chuenyam T, Duncombe C, Bebchuk JD, Wendler D, et al. The quality of informed consent in a clinical research study in Thailand. IRB: Ethics & Human Research. 2005;27:9–17. [PubMed] [Google Scholar]
  77. Pace C, Talisuna A, Wendler D, Maiso F, Wabwire-Mangen F, Bakyaita N, et al. Quality of parental consent in a Ugandan malaria study. American Journal of Public Health. 2005;95(7):1184–1189. doi: 10.2105/AJPH.2004.053082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Penn C, Evans M. Assessing the impact of a modified informed consent process in a South African HIV/AIDS research trial. Patient Education and Counseling. 2010;80(2):191–199. doi: 10.1016/j.pec.2009.10.019. [DOI] [PubMed] [Google Scholar]
  79. Quinn SC. Ethics in public health research: Protecting human subjects—The role of community advisory boards. American Journal of Public Health. 2004;94(6):918–922. doi: 10.2105/ajph.94.6.918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Ragin DF, Ricci E, Rhodes R, Holohan J, Smirnoff M, Richardson LD. Defining the “community” in community consultation for emergency research: findings from the community VOICES study. Social Science and Medicine. 2008;66(6):1379–1392. doi: 10.1016/j.socscimed.2007.10.022. [DOI] [PubMed] [Google Scholar]
  81. Reddy P, Buchanan D, Sifunda S, James S, Naidoo N. The role of community advisory boards in health research: Divergent views in the South African experience. SAHARA–J: Journal of Social Aspects of HIV/AIDS. 2010;7(3):2–8. doi: 10.1080/17290376.2010.9724963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Reynolds L, Cousins T, Newell ML, Imrie J. The social dynamics of consent and refusal in HIV surveillance in rural South Africa. Social Science and Medicine. 2013;77:118–125. doi: 10.1016/j.socscimed.2012.11.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Sarkar R, Sowmyanarayanan TV, Samuel P, Singh AS, Bose A, Muliyil J, Kang G. Comparison of group counseling with individual counseling in the comprehension of informed consent: A randomized controlled trial. BMC Medical Ethics. 2010;11:8. doi: 10.1186/1472-6939-11-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Shore N, Wong KA, Seifer SD, Grignon J, Gamble VN. Introduction to special issue: Advancing the ethics of community-based participatory research. Journal of Empirical Research on Human Research Ethics. 2008;3(2):1–4. doi: 10.1525/jer.2008.3.2.1. [DOI] [PubMed] [Google Scholar]
  85. Shubis K, Juma O, Sharifu R, Burgess B, Abdulla S. Challenges of establishing a community advisory board (CAB) in a low-income, low-resource setting: Experiences from Bagamoyo, Tanzania. Health Research Policy and Systems. 2009;7:16. doi: 10.1186/1478-4505-7-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Slevin K, Morenike U, Lori H. Community engagement in HIV prevention trials: Evolution of the field and opportunities for growth. 2013 AIDS 2013 Background Paper at www.path.org/publications/files/s2031_comm_engage.pdf.
  87. Strauss RP, Sengupta S, Quinn SC, Goeppinger J, Spaulding C, Kegeles SM, Millett G. The role of community advisory boards: Involving communities in the informed consent process. American Journal of Public Health. 2001;91(12):1938–1943. doi: 10.2105/ajph.91.12.1938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Tekola F, Bull S, Farsides B, Newport MJ, Adeyemo A, Rotimi CN, Davey G. Impact of social stigma on the process of obtaining informed consent for genetic research on podoconiosis: A qualitative study. BMC Medical Ethics. 2009a;10:13. doi: 10.1186/1472-6939-10-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Tekola F, Bull SJ, Farsides B, Newport MJ, Adeyemo A, Rotimi CN, Davey G. Tailoring consent to context: Designing an appropriate consent process for a biomedical study in a low-income setting. PLoS Neglected Tropical Diseases. 2009b;3(7):e482. doi: 10.1371/journal.pntd.0000482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Terry SF, Terry PF, Rauen KA, Uitto J, Bercovitch LG. Advocacy groups as research organizations: The PXE International example. Nature Review Genetics. 2007;8:157–164. doi: 10.1038/nrg1991. [DOI] [PubMed] [Google Scholar]
  91. Tindana P, Bull S, Amenga-Etego L, de Vries J, Aborigo R, Koram K, et al. Seeking consent to genetic and genomic research in a rural Ghanaian setting: A qualitative study of the MalariaGEN experience. BMC Medical Ethics. 2012;13:15. doi: 10.1186/1472-6939-13-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Tindana PO, Kass N, Akweongo P. The informed consent process in a rural African setting: A case study of the Kassena-Nankana District of Northern Ghana. IRB: Ethics & Human Research. 2006;28:1–6. [PMC free article] [PubMed] [Google Scholar]
  93. Tindana PO, Rozmovits L, Boulanger RF, Bandewar SV, Aborigo RA, Hodgson AV, et al. Aligning community engagement with traditional authority structures in global health research: A case study from northern Ghana. American Journal of Public Health. 2011;101(10):1857–1867. doi: 10.2105/AJPH.2011.300203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Tindana PO, Singh JA, Tracy CS, Upshur RE, Daar AS, Singer PA, et al. Grand challenges in global health: Community engagement in research in developing countries. PLoS Medicine. 2007;4(9):e273. doi: 10.1371/journal.pmed.0040273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Treffry-Goatley A, Mahlinza M, Imrie J. Public engagement with HIV/AIDS in a rural, South African context: An analysis of a low-budget, small media, taxi-based, edutainment model applied in Jiving with Science. Critical Arts and Education. 2013 in press. [Google Scholar]
  96. UNAIDS (Joint United Nations Programme on HIV/AIDS) Good participatory practice guidelines for biomedical HIV prevention trials. 2nd ed. UNAIDS; Geneva: 2011. [Google Scholar]
  97. United States National Bioethics Advisory Commission . Ethical and policy issues in international research: Clinical trials in developing countries, Vol. II, Commissioned papers and staff analysis. National Bioethics Advisory Commission; Bethesda, MD: 2001. [Google Scholar]
  98. Vallely A, Lees S, Shagi C, Kasindi S, Soteli S, Kavit N, et al. How informed is consent in vulnerable populations? Experience using a continuous consent process during the MDP301 vaginal microbicide trial in Mwanza, Tanzania. BMC Medical Ethics. 2010;11:10. doi: 10.1186/1472-6939-11-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Vanlerbergh e V, Toledo ME, Rodriguez M, Gomez D, Baly A, Benitez, et al. Community involvement in dengue vector control: Cluster randomized trial. British Medical Journal. 2009;338 doi: 10.1136/bmj.b1959. b:1959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Woodsong C, Karim QA. A model designed to enhance informed consent: Experiences from the HIV prevention trials network. American Journal of Public Health. 2005;95(3):412–419. doi: 10.2105/AJPH.2004.041624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. World Medical Association In: World Medical Assembly, editor. Declaration of Helsinki; 59th World Medical Assembly; Seoul. 2008; [Google Scholar]

RESOURCES